Litcius/Paper detail

Immune-checkpoint inhibition for resectable non-small-cell lung cancer — opportunities and challenges

Giannis Mountzios, Jordi Remón, Lizza Hendriks, Rosario García‐Campelo, Christian Rolfo, Paul Van Schil, Patrick M. Forde, Benjamin Besse, Vivek Subbiah, Martin Reck, Jean‐Charles Soria, Solange Peters

2023Nature Reviews Clinical Oncology182 citationsDOIOpen Access PDF

Topics & Concepts

MedicineOncologyClinical trialLung cancerClinical endpointNeoadjuvant therapyInternal medicineImmunotherapyPerioperativeAdjuvantStage (stratigraphy)DiseaseChemotherapyCancerIntensive care medicineSurgeryBiologyPaleontologyBreast cancerCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsCancer Genomics and Diagnostics
Immune-checkpoint inhibition for resectable non-small-cell lung cancer — opportunities and challenges | Litcius